ConductScience.org, home

Paper41516293

miRNA in the Progression of Diabetic Kidney Disease: New Insight.

Zou Z and 2 others. Int J Mol Sci, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. miRNA in the Progression of Diabetic Kidney Disease: New Insight. Papers, record 41516293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41516293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
miRNA in the Progression of Diabetic Kidney Disease: New Insight.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.53, provisional
iCite
Revised in PubMed
2026-06-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zou ZZhiyue
2Zhou NNinghttps://orcid.org/0000-0001-9667-9115
3Zhang CChunhttps://orcid.org/0000-0003-3565-8024

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetic NephropathiesMajor topic
MicroRNAsMajor topic
Humans
Disease Progression
Animals
Biomarkers
Signal Transduction
Gene Expression Regulation

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82570881National Natural Science Foundation of ChinaPubMed
82470771National Natural Science Foundation of ChinaPubMed
82370728National Natural Science Foundation of ChinaPubMed
82570823National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References126

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124887517miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.Mol Cell Endocrinol2014https://conductscience.org/library/papers/24887517PubMed
228522654Diabetic Kidney Disease: Challenges, Progress, and Possibilities.Clin J Am Soc Nephrol2017https://conductscience.org/library/papers/28522654PubMed
325182190Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury.BMC Nephrol2014https://conductscience.org/library/papers/25182190PubMed
432238921Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.Br J Cancer2020https://conductscience.org/library/papers/32238921PubMed
537138859MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis.Front Immunol2023https://conductscience.org/library/papers/37138859PubMed
631447320Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease.Cell Metab2019https://conductscience.org/library/papers/31447320PubMed
737365583Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study.J Hematol Oncol2023https://conductscience.org/library/papers/37365583PubMed
832587662miR-155-5p Implicates in the Pathogenesis of Renal Fibrosis via Targeting SOCS1 and SOCS6.Oxid Med Cell Longev2020https://conductscience.org/library/papers/32587662PubMed
927522360Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.Endocrine2017https://conductscience.org/library/papers/27522360PubMed
1017786230MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.J Clin Invest2007https://conductscience.org/library/papers/17786230PubMed
1126898629Diabetic nephropathy: MiR-23b protects against fibrosis in diabetic nephropathy.Nat Rev Nephrol2016https://conductscience.org/library/papers/26898629PubMed
1219165215Biogenesis of small RNAs in animals.Nat Rev Mol Cell Biol2009https://conductscience.org/library/papers/19165215PubMed
1325750628MicroRNAs in renal fibrosis.Front Physiol2015https://conductscience.org/library/papers/25750628PubMed
1418955434Most mammalian mRNAs are conserved targets of microRNAs.Genome Res2009https://conductscience.org/library/papers/18955434PubMed
1534522205Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys.Theranostics2021https://conductscience.org/library/papers/34522205PubMed
1619351599MicroRNA-221 regulates high glucose-induced endothelial dysfunction.Biochem Biophys Res Commun2009https://conductscience.org/library/papers/19351599PubMed
1729127220Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.Physiol Genomics2018https://conductscience.org/library/papers/29127220PubMed
1839309435MicroRNA-29b Plays a Vital Role in Podocyte Injury and Glomerular Diseases through Inducing Mitochondrial Dysfunction.Int J Biol Sci2024https://conductscience.org/library/papers/39309435PubMed
1931702814Effects of microRNA‑217 on high glucose‑induced inflammation and apoptosis of human retinal pigment epithelial cells (ARPE‑19) and its underlying mechanism.Mol Med Rep2019https://conductscience.org/library/papers/31702814PubMed
2036675311MicroRNAs Associated with Chronic Kidney Disease in the General Population and High-Risk Subgroups-A Systematic Review.Int J Mol Sci2023https://conductscience.org/library/papers/36675311PubMed

See all 126 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42958439Inflammatory networks between adipose tissue, liver and pancreatic islets in type 2 diabetes.Hum Genomics2026https://conductscience.org/library/papers/42958439PubMed
42939514Fully Complementary Interactions of Human mRNA Genes with miRNAs from NCBI Database.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42939514PubMed
42930010Advanced Therapies for Diabetic Kidney Disease: A Critical Review of Gene-, RNA-, and Cell-Based Strategies to Address Residual Risk.Diseases2026https://conductscience.org/library/papers/42930010PubMed
42846585Novel applications of SIRT1 in Chronic Kidney Disease.Front Med (Lausanne)2026https://conductscience.org/library/papers/42846585PubMed
42783420Targeting MicroRNA-21 in Chronic Kidney Disease: Lessons from the Lademirsen Story.Med Sci (Basel)2026https://conductscience.org/library/papers/42783420PubMed
42506451
Extracellular Vesicle-Associated microRNAs as Candidate Biomarkers and Mediators of Diabetic Complications: Clinical and Translational Evidence Across Neuropathy, Diabetic Kidney Disease, Retinopathy, and MASLD.
Metabolites2026https://conductscience.org/library/papers/42506451PubMed
42353293Extracellular Vesicle-Derived MicroRNAs as Early Diagnostic Biomarkers of Diabetic Nephropathy and Cardiovascular Diseases in Type 2 Diabetes.Int J Mol Sci2026https://conductscience.org/library/papers/42353293PubMed
42343466Silymarin attenuates diabetic nephropathy in rats via modulation of the miRNA-223/NLRP3/caspase-1/GSDMD axis and inflammasome-related pyroptotic signaling.Biol Direct2026https://conductscience.org/library/papers/42343466PubMed
42100367Translational insights into miR-126 and miR-423: biomarkers and therapeutic targets in cancer, cardiovascular, metabolic and kidney diseases.Front Mol Biosci2026https://conductscience.org/library/papers/42100367PubMed
42041569The Role of Non-Coding RNA in the Pathogenesis of Hypertensive Nephropathy.Cells2026https://conductscience.org/library/papers/42041569PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MIR192406967PubTator's text mininghttps://conductscience.org/library/genes/406967NCBI Gene
MIR21406991PubTator's text mininghttps://conductscience.org/library/genes/406991NCBI Gene
MIR214406996PubTator's text mininghttps://conductscience.org/library/genes/406996NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41516293

GET https://conductscience.org/api/papers/v1/41516293/references?page=2